🔗 Permalink

Inventor profile of:

Dalton King

City:

Hamden, Connecticut

Country:

United States

Published Applications:

Last publication date:

2021-04-29

Top Assignees for applications by Dalton King

The entities that hold a legal rights for patent applications filed by inventor King Dalton:

BRISTOL-MYERS SQUIBB COMPANY 11 Princeton, NJ United States
Bristol-Myers Squibb Company 1 Frinceton, NJ United States

Recent patent applications by King Dalton

Dalton King from Hamden, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-04-29

US20210121453A1

Human necessities

SELECTIVE NR2B ANTAGONISTS

#2 | 2020-05-28

US20200163949A1

Human necessities

SELECTIVE NR2B ANTAGONISTS

#3 | 2019-10-17

US20190314358A1

Human necessities

SELECTIVE NR2B ANTAGONISTS

#4 | 2019-04-25

US20190117638A1

Human necessities

SELECTIVE NR2B ANTAGONISTS

#5 | 2018-09-06

US20180250283A1

Human necessities

SELECTIVE NR2B ANTAGONISTS

#6 | 2018-04-26

US20180110766A1

Human necessities

SELECTIVE NR2B ANTAGONISTS

#7 | 2018-01-04

US20180000807A1

Human necessities

SELECTIVE NR2B ANTAGONISTS

#8 | 2017-09-14

US20170258777A1

Human necessities

Selective NR2B Antagonists

#9 | 2016-04-14

US20160101104A1

Human necessities

QUINUCLIDINE COMPOUNDS AS ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS

#10 | 2016-03-24

US20160081995A1

Human necessities

Selective NR2B Antagonists

#11 | 2015-12-03

US20150342935A1

Human necessities

QUINUCLIDINE COMPOUNDS AS ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS

#12 | 2015-07-09

US20150191452A1

Chemistry; metallurgy

Selective NR2B antagonists

#13 | 2015-04-02

US20150094309A1

Chemistry; metallurgy

QUINUCLIDINE COMPOUNDS AS ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS

#14 | 2014-08-07

US20140221377A1

Chemistry; metallurgy

Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands

#15 | 2013-05-23

US20130131064A1

Chemistry; metallurgy

Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands

#16 | 2013-04-04

US20130085138A1

Chemistry; metallurgy

Selective NR2B antagonists

#17 | 2013-03-28

US20130079338A1

Chemistry; metallurgy

Selective NR2B antagonists

#18 | 2012-05-03

US20120108596A1

Chemistry; metallurgy

Aza-bicyclic amine N-oxide compounds as alpha-7 nicotinic acetylcholine receptor ligand pro-drugs

#19 | 2012-02-09

US20120035189A1

Human necessities

Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands

#20 | 2012-02-09

US20120035178A1

Human necessities

Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands

#21 | 2011-11-03

US20110269787A1

Chemistry; metallurgy

Azabicyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands

#22 | 2011-10-27

US20110263605A1

Chemistry; metallurgy

Azabicyclo[2.2.1]heptane compounds as alpha-7 nicotinic acetylcholine receptor ligands

#23 | 2010-09-23

US20100240708A1

Chemistry; metallurgy

Alpha-(N-benzenesulfonamido)cycloalkyl derivatives

#24 | 2010-04-22

US20100099684A1

Human necessities

Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligands

#25 | 2009-10-29

US20090270405A1

Chemistry; metallurgy

Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands

#26 | 2006-09-12

US10662493

Compounds for the treatment of premature ejaculation

#27 | 2006-05-23

US10662745

Cyclopentyl indole derivatives

InventorID:

167428 ⎘